MDYSP - Overview: Inherited Muscular Dystrophy Gene Panel, Varies
Establishing a molecular diagnosis for patients with muscular dystrophy Identifying variants within genes known to be associated with muscular dystrophy, allowing for predictive testing of at-risk family members
ALUPP - Overview: Lupus Anticoagulant Profile, Plasma
Confirming or excluding the presence of lupus anticoagulant (LA), distinguishing LA from specific coagulation factor inhibitors and nonspecific inhibitors Investigating a prolonged activated thromboplastin time, especially when combined...
Detecting drug use involving stimulants, barbiturate, benzodiazepines, cocaine, opioids, tetrahydrocannabinol, and alcohol This test is not intended for use in employment-related testing.
Identification of individuals who may be at risk for aminoglycoside-induced hearing loss (AIHL) Establishing a diagnosis of late-onset sensorineural hearing loss associated with aminoglycoside exposure Identifying mitochondrial variants...
AATTA - Overview: Antithrombin Summary Interpretation
Diagnosis of antithrombin deficiency, acquired or congenital Monitoring treatment of antithrombin deficiency disorders, including infusion of antithrombin therapeutic concentrate
BETV2 - Overview: BET v2 (Profilin), IgE, Serum
Evaluation of patients suspected birch pollen allergy Evaluation of patients with suspected peanut allergy Evaluation of patients with oral allergy syndrome to other pollens or plant-based foods Testing for IgE antibodies is not useful...
CITR - Overview: Citrate Excretion, 24 Hour, Urine
Diagnosing risk factors for patients with calcium kidney stones Monitoring results of therapy in patients with calcium stones or renal tubular acidosis
KRASD - Overview: Cell-Free DNA KRAS 12, 13, 61,146, Blood
An alternative to invasive tissue biopsies for the determination of KRAS 12, 13, 61,146 (G12A, G12C, G12D, G12R, G12S, G12V, G13D, Q61K, Q61L, Q61R, Q61H, and A146T) mutation status Detecting molecular markers associated with response or...
CYPAN - Overview: Cytokine Panel, Plasma
Understanding the etiology of infectious or chronic inflammatory diseases, when used in conjunction with clinical information and other laboratory testing Research studies in which an assessment of cytokine responses is needed
DNSAG - Overview: Dengue Virus NS1 Antigen, Serum
Aiding in the diagnosis of dengue virus infection
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...